首页> 外文期刊>International Journal of Pharmaceutics >Poly(epsilon-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release
【24h】

Poly(epsilon-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release

机译:聚(ε-己内酯)/三氯生负载的聚乳酸纳米粒子复合材料:具有缓释作用的长期抗菌生物纳米复合材料

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In this study, the antibacterial bionanocomposites of poly(epsilon-caprolactone) (PCL) with different concentrations of triclosan (TC) loaded polylactic acid (PLA) nanoparticles (30 wt% triclosan) (LATC30) were fabricated via a melt mixing process in order to lower the burst release of PCL and to extend the antibacterial activity during its performance. Due to the PLA's higher glass transition temperature (T-g) and less flexibility compared with PCL; the PLA nanoparticles efficiently trapped the TC particles, reduced the burst release of TC from the bionanocomposites; and extended the antibacterial property of the samples up to two years. The melt mixing temperature was adjusted to a temperature lower than the melting point of LATC30 nanoparticles; therefore, these nanoparticles were dispersed in the PCL matrix without any chemical reaction and/or drug extraction. The sustained release behavior of TC from PCL remained unchanged since no significant changes occurred in the samples' crystallinity compared with that in the neat PCL. The elastic moduli of samples were enhanced once LATC30 is included. This is necessary since the elastic modulus is decreased with water absorption. The rheological behaviors of samples showed appropriate properties for melt electro-spinning. A stable process was established as the relaxation time of the bionanocomposites was increased. The hydrophilic properties of samples were increased with increasing LATC30. The proliferation rate of the fibroblast (L929) cells was enhanced as the content of nanoparticles was increased. A system similar to this could be implemented to prepare long-term antibacterial and drug delivery systems based on PCL and various low molecular weight drugs. The prepared bionanocomposites are considered as candidates for the soft connective tissue engineering and long-term drug delivery. (C) 2016 Elsevier B.V. All rights reserved.
机译:在这项研究中,通过熔融混合工艺制备了具有不同浓度的负载三氯生(TC)的聚乳酸(PLA)纳米颗粒(30 wt%三氯生)(LATC30)的聚(ε-己内酯)(PCL)抗菌复合材料。降低PCL的爆发释放并在其性能过程中扩展抗菌活性。与PCL相比,由于PLA的玻璃化转变温度(T-g)高,柔韧性低; PLA纳米颗粒有效地捕获了TC颗粒,减少了从生物纳米复合材料中TC的突发释放。并将样品的抗菌性能延长至两年。将熔体混合温度调节至低于LATC30纳米颗粒的熔点的温度;即,将其调节至低于LATC30纳米颗粒的熔点。因此,这些纳米颗粒分散在PCL基质中,没有任何化学反应和/或药物提取。 TC从PCL的持续释放行为保持不变,因为与纯PCL相比,样品的结晶度没有发生明显变化。一旦包含LATC30,样品的弹性模量就会提高。这是必要的,因为弹性模量随着吸水而降低。样品的流变行为显示出适合熔体静电纺丝的特性。随着仿生复合材料弛豫时间的增加,建立了稳定的过程。样品的亲水性随LATC30的增加而增加。随着纳米颗粒含量的增加,成纤维细胞(L929)的增殖速率增加。可以使用与此类似的系统来制备基于PCL和各种低分子量药物的长期抗菌和药物输送系统。制备的生物纳米复合材料被认为是软性结缔组织工程和长期药物输送的候选者。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号